Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
Clips
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are transforming cancer care and why listening to patients is the key to it all.
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are transforming cancer care and why listening to patients is the key to it all.
Dr. Gray highlights City of Hope’s leadership in precision medicine, from expanded germline testing and the INSPIRE program to emerging early‑detection studies using whole‑body MRI and liquid biopsy. The episode dissects how system‑wide integration and new technologies can expand access to expert opinions, match patients to clinical trials and ensure high‑quality cancer care, regardless of a patient’s geographic location.
Oncologists sometimes worry that sharing genomic results without concrete recommendations may increase patients’ anxiety. But as Dr. Gray notes, research shows that what patients want most is actionable information that helps them understand what comes next. Her work has helped catalyze innovations such as molecular tumor boards and large‑scale genomic programs that make testing more accessible and clinically meaningful.